Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Ebert

Showing results (111-120 of 339) with videos related to

Pageof 34
Sort By:
Blood|October 5, 2014
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasmsEdwin Chen, Rebekka K Schneider, Lawrence J Breyfogle, et al.
Genome Research|October 3, 2015
Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cellsMonika S Kowalczyk, Itay Tirosh, Dirk Heckl, et al.
Nature Communications|January 19, 2020
Rapid and deep-scale ubiquitylation profiling for biology and translational researchNamrata D Udeshi, Deepak C Mani, Shankha Satpathy, et al.
Journal of the American College of Cardiology|May 24, 2023
Increased Risk of Thoracic Aortic Aneurysms With JAK2 V617FTetsushi Nakao, Zhi Yu, Caitlyn Vlasschaert, et al.
Science (New York, N.Y.)|December 17, 2013
Genome-scale CRISPR-Cas9 knockout screening in human cellsOphir Shalem, Neville E Sanjana, Ella Hartenian, et al.
Science (New York, N.Y.)|February 9, 2013
(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversibleJulie-Aurore Losman, Ryan E Looper, Peppi Koivunen, et al.
Plos One|May 3, 2014
Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosisSerena De Vita, Rebekka K Schneider, Michael Garcia, et al.
Nature|January 19, 2008
Identification of RPS14 as a 5q- syndrome gene by RNA interference screenBenjamin L Ebert, Jennifer Pretz, Jocelyn Bosco, et al.
EMBO Molecular Medicine|March 8, 2017
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with <i>TP53</i> mutationsRam Ajore, David Raiser, Marie McConkey, et al.
The Journal of Clinical Investigation|September 7, 2016
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemiaPatrick D Bhola, Brenton G Mar, R Coleman Lindsley, et al.
Pageof 34

Showing results (111-120 of 339) with videos related to

Sort By:
Pageof 34
Blood|October 5, 2014
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasmsEdwin Chen, Rebekka K Schneider, Lawrence J Breyfogle, et al.
Genome Research|October 3, 2015
Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cellsMonika S Kowalczyk, Itay Tirosh, Dirk Heckl, et al.
Nature Communications|January 19, 2020
Rapid and deep-scale ubiquitylation profiling for biology and translational researchNamrata D Udeshi, Deepak C Mani, Shankha Satpathy, et al.
Journal of the American College of Cardiology|May 24, 2023
Increased Risk of Thoracic Aortic Aneurysms With JAK2 V617FTetsushi Nakao, Zhi Yu, Caitlyn Vlasschaert, et al.
Science (New York, N.Y.)|December 17, 2013
Genome-scale CRISPR-Cas9 knockout screening in human cellsOphir Shalem, Neville E Sanjana, Ella Hartenian, et al.
Science (New York, N.Y.)|February 9, 2013
(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversibleJulie-Aurore Losman, Ryan E Looper, Peppi Koivunen, et al.
Plos One|May 3, 2014
Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosisSerena De Vita, Rebekka K Schneider, Michael Garcia, et al.
Nature|January 19, 2008
Identification of RPS14 as a 5q- syndrome gene by RNA interference screenBenjamin L Ebert, Jennifer Pretz, Jocelyn Bosco, et al.
EMBO Molecular Medicine|March 8, 2017
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with <i>TP53</i> mutationsRam Ajore, David Raiser, Marie McConkey, et al.
The Journal of Clinical Investigation|September 7, 2016
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemiaPatrick D Bhola, Brenton G Mar, R Coleman Lindsley, et al.
Pageof 34